Development and characterization of phospho-ubiquitin antibodies to monitor PINK1-PRKN signaling in cells and tissue
Jens O. Watzlawik(Mayo Clinic in Florida), Wolfdieter Springer(WinnMed)
Cited by 9
Related Papers
Heterozygous PINK1 p.G411S increases risk of Parkinson’s disease via a dominant-negative mechanism
|Brain|2016|142
Alpha‐synuclein‐associated changes in PINK1‐PRKN‐mediated mitophagy are disease context dependent
|Brain Pathology|2023|41
Alterations of PINK1-PRKN signaling in mice during normal aging
|Autophagy Reports|2024|10
Genome‐wide association analysis identifies <i>APOE</i> as a mitophagy modifier in Lewy body disease
|Alzheimer s & Dementia|2025|7